XML 17 R7.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENT OF SHAREHOLDERS' EQUITY (unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Retained Earnings
Accumulated Other Comprehensive Loss
Beginning balance at Jan. 02, 2021 $ 209,019 $ 503 $ 216,999 $ (8,483)
Beginning balance (in shares) at Jan. 02, 2021   7,693,497    
Increase (Decrease) in Shareholders' Equity        
Net income 10,501   10,501  
Foreign currency translation adjustment (111)     (111)
Issuance of restricted common stock for contingent consideration 2,250 $ 2,250    
Issuance of restricted common stock for contingent consideration (in shares)   40,039    
Exercise of stock options 1,113 $ 1,113    
Exercise of stock options (in shares)   41,008    
Share-based compensation expense 842 $ 842    
Restricted shares vesting (in shares)   29,494    
Redemption of vested employee restricted shares for tax withholding (588) $ (588)    
Redemption of vested employee restricted shares for tax withholding (in shares)   (9,895)    
Shares repurchased (9,642) $ (4,120) (5,522)  
Shares repurchased (in shares)   (166,552)    
Accrued dividends on unvested shares 5   5  
Cash dividends paid (per share) (2,061)   (2,061)  
Ending balance at Apr. 03, 2021 211,328 $ 0 219,922 (8,594)
Ending balance (in shares) at Apr. 03, 2021   7,627,591    
Beginning balance at Jan. 02, 2021 209,019 $ 503 216,999 (8,483)
Beginning balance (in shares) at Jan. 02, 2021   7,693,497    
Increase (Decrease) in Shareholders' Equity        
Net income 22,067      
Foreign currency translation adjustment (247)      
Issuance of restricted common stock for contingent consideration 2,250      
Ending balance at Jul. 03, 2021 197,831 $ 1,985 204,576 (8,730)
Ending balance (in shares) at Jul. 03, 2021   7,339,322    
Beginning balance at Apr. 03, 2021 211,328 $ 0 219,922 (8,594)
Beginning balance (in shares) at Apr. 03, 2021   7,627,591    
Increase (Decrease) in Shareholders' Equity        
Net income 11,566   11,566  
Foreign currency translation adjustment (136)     (136)
Exercise of stock options 1,387 $ 1,387    
Exercise of stock options (in shares)   48,562    
Share-based compensation expense 980 $ 980    
Restricted shares vesting (in shares)   1,006    
Shares repurchased (25,335) $ (382) (24,953)  
Shares repurchased (in shares)   (337,837)    
Accrued dividends on unvested shares (50)   (50)  
Cash dividends paid (per share) (1,909)   (1,909)  
Ending balance at Jul. 03, 2021 197,831 $ 1,985 204,576 (8,730)
Ending balance (in shares) at Jul. 03, 2021   7,339,322    
Beginning balance at Jan. 01, 2022 $ 205,834 $ 0 215,784 (9,950)
Beginning balance (in shares) at Jan. 01, 2022 7,362,703 7,362,703    
Increase (Decrease) in Shareholders' Equity        
Net income $ 11,426   11,426  
Foreign currency translation adjustment (1,172)     (1,172)
Exercise of stock options 341 $ 341    
Exercise of stock options (in shares)   14,552    
Share-based compensation expense 1,037 $ 1,037    
Restricted shares vesting (in shares)   29,558    
Redemption of vested employee restricted shares for tax withholding (897) $ (897)    
Redemption of vested employee restricted shares for tax withholding (in shares)   (10,163)    
Shares repurchased (4,956) $ (481) (4,475)  
Shares repurchased (in shares)   (56,665)    
Accrued dividends on unvested shares (11)   (11)  
Cash dividends paid (per share) (2,377)   (2,377)  
Ending balance at Apr. 02, 2022 209,225 $ 0 220,347 (11,122)
Ending balance (in shares) at Apr. 02, 2022   7,339,985    
Beginning balance at Jan. 01, 2022 $ 205,834 $ 0 215,784 (9,950)
Beginning balance (in shares) at Jan. 01, 2022 7,362,703 7,362,703    
Increase (Decrease) in Shareholders' Equity        
Net income $ 23,069      
Foreign currency translation adjustment (5,032)      
Issuance of restricted common stock for contingent consideration 0      
Ending balance at Jul. 02, 2022 $ 197,986 $ 0 212,968 (14,982)
Ending balance (in shares) at Jul. 02, 2022 7,131,349 7,131,349    
Beginning balance at Apr. 02, 2022 $ 209,225 $ 0 220,347 (11,122)
Beginning balance (in shares) at Apr. 02, 2022   7,339,985    
Increase (Decrease) in Shareholders' Equity        
Net income 11,643   11,643  
Foreign currency translation adjustment (3,860)     (3,860)
Share-based compensation expense 1,041 $ 1,041    
Restricted shares vesting (in shares)   3,630    
Redemption of vested employee restricted shares for tax withholding (78) $ (78)    
Redemption of vested employee restricted shares for tax withholding (in shares)   (921)    
Shares repurchased (17,674) $ (963) (16,711)  
Shares repurchased (in shares)   (211,345)    
Accrued dividends on unvested shares (52)   (52)  
Cash dividends paid (per share) (2,259)   (2,259)  
Ending balance at Jul. 02, 2022 $ 197,986 $ 0 $ 212,968 $ (14,982)
Ending balance (in shares) at Jul. 02, 2022 7,131,349 7,131,349